| 000 | 01425 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516164039.0 | ||
| 264 | 0 | _c20141015 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1477-111X | ||
| 024 | 7 |
_a10.1177/0267659113499782 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLong, M T | |
| 245 | 0 | 0 |
_aSafety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review. _h[electronic resource] |
| 260 |
_bPerfusion _cMar 2014 |
||
| 300 |
_a163-70 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aBlood Component Transfusion |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aExtracorporeal Membrane Oxygenation _xadverse effects |
| 650 | 0 | 4 |
_aFactor VIIa _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Records, Personal |
| 650 | 0 | 4 |
_aHemorrhage _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aWagner, D | |
| 700 | 1 | _aMaslach-Hubbard, A | |
| 700 | 1 | _aPasko, D A | |
| 700 | 1 | _aBaldridge, P | |
| 700 | 1 | _aAnnich, G M | |
| 773 | 0 |
_tPerfusion _gvol. 29 _gno. 2 _gp. 163-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0267659113499782 _zAvailable from publisher's website |
| 999 |
_c23001797 _d23001797 |
||